| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/10/2008 | WO2007121491A8 Hcv vaccinations |
| 01/10/2008 | WO2007120079A3 4-aminomethyl-6-bromine-5-hydroxyindol-3-carboxilate derivatives, method for the production (variants) and the use thereof |
| 01/10/2008 | WO2007117715A3 Modulators of atp-binding cassette transporters |
| 01/10/2008 | WO2007116313A3 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| 01/10/2008 | WO2007112835A3 Medicaments and/or food supplements comprising nisylene, cepa, euphrasia, belladonna and/or mercurius solubilis |
| 01/10/2008 | WO2006130500A8 Tigecycline and methods of preparing 9-aminominocycline |
| 01/10/2008 | WO2006108879A3 Use of a sulfonamide compound for improving the pharmacokinetics of a drug |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009535 Inhibitors of phosphodiesterase type-IV |
| 01/10/2008 | US20080009528 such as 4-(2,4-dichlorophenyl)-6-(3-hydroxyphenyl)-2-methyl-3-cyanopyridine, used for inhibiting growth of Gram-positive bacteria selected from Bacillus, Listeria, Staphylococcus, Streptococcus, Enterococcus, Corynebacterium, Propionibacterium and Clostridium |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid |
| 01/10/2008 | US20080009496 Mutagenic heterocycles |
| 01/10/2008 | US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione |
| 01/10/2008 | US20080009483 3-{[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]methyl}-N-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-4-hydroxycyclopentanecarboxamide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/10/2008 | US20080009468 Method for reducing psa levels |
| 01/10/2008 | US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates |
| 01/10/2008 | US20080009459 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009445 Anti-endotoxic, antimicrobial cationic peptides, the encoding DNA and methods of use thereof |
| 01/10/2008 | US20080009442 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis |
| 01/10/2008 | US20080009022 Immunization of dairy cattle with chimeric gapC protein against streptococcus infection |
| 01/10/2008 | US20080008771 Nitric Oxide Dioxygenase Inhibitors |
| 01/10/2008 | US20080008723 comprising a conserved di-glucosyl -tri-heptosyl inner-core moiety ; Actinobacillus pleuropneumoniae (Ap), Mannheimia haemolytica (Mh) and Pasteurella multocida (Pm); toxoids |
| 01/10/2008 | US20080008718 Ornithobacterium Rhinotracheale Subunit Vaccines |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings |
| 01/10/2008 | US20080008681 Macrocyclic hepatitis c virus serine protease inhibitors |
| 01/10/2008 | CA2660031A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 01/10/2008 | CA2657035A1 Novel inhibitors of hepatitis c virus replication |
| 01/10/2008 | CA2656959A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | CA2656756A1 Toxin detection method |
| 01/10/2008 | CA2656427A1 Modulators of toll-like receptor 7 |
| 01/10/2008 | CA2656356A1 Antiviral phosphinate compounds |
| 01/10/2008 | CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1875913A1 Compositions and method for treating infection in cattle and swine |
| 01/09/2008 | EP1875910A1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine |
| 01/09/2008 | EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives |
| 01/09/2008 | EP1874918A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| 01/09/2008 | EP1874806A2 Vaccine against burkholderia infections |
| 01/09/2008 | EP1874804A2 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 01/09/2008 | EP1874344A1 C. perfringens alpha toxoid vaccine |
| 01/09/2008 | EP1874327A1 Antiviral peptides |
| 01/09/2008 | EP1874312A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 01/09/2008 | EP1874307A2 Use of a sulfonamide compound for improving the pharmacokinetics of a drug |
| 01/09/2008 | EP1874136A2 Nutritional supplement for a category of hiv patients |
| 01/09/2008 | EP1874116A1 Compounds, pharmaceutical compositions and methods for inhibiting hiv infectivity |
| 01/09/2008 | EP1682146B1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 01/09/2008 | EP1605927B1 Anti-microbially active diamine-based guanine derivatives |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1311270B1 Non-sedating barbiturate compounds as neuroprotective agents |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1223935B1 Use of gemifloxacin compounds against bacteria |
| 01/09/2008 | EP1129196B1 Virulence genes and proteins, and their use |
| 01/09/2008 | EP0988042B1 Combination of product r and an antiviral agent in the therapy of hiv infections |
| 01/09/2008 | CN101103043A Kir-binding agents and methods of use thereof |
| 01/09/2008 | CN101103029A 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
| 01/09/2008 | CN101102794A Compositions against sars-coronavirus and uses thereof |
| 01/09/2008 | CN101100665A Method for preparing animal general purpose recombinant alpha interferon |
| 01/09/2008 | CN101100664A Method for preparing recombinant canine alpha-type interferon |
| 01/09/2008 | CN101100483A Analogue of muramyl dipeptide |
| 01/09/2008 | CN101100474A Fluoroquinolone compound containing phosphate ester group and its preparation method and use |
| 01/09/2008 | CN101100470A Tetranuclear bipyrane coumarin compound |
| 01/09/2008 | CN101100469A Novel crystal of doripenem, preparation method and use thereof |
| 01/09/2008 | CN101100468A Doriipenem hydrate crystal and preparation method thereof |
| 01/09/2008 | CN101100432A Method for synthesizing benzyldimethyl[3-(myristamide)propyl]ammonium chloride |
| 01/09/2008 | CN101099869A Method for using siRNA composition to treat disease and improve siRNA effect in RNAi |
| 01/09/2008 | CN101099868A Material compound for synthesizing norfloxacin macromolecular prodrug with active monomer and preparation method thereof |
| 01/09/2008 | CN101099862A Inactivated vaccine for preventing monkey from SV40 virus infection and preparation method |
| 01/09/2008 | CN101099857A Compound Chinese and Western medicine preparation for treating ringworm of hand or foot and onychomycosis and preparation method and quality control method thereof |
| 01/09/2008 | CN101099852A Traditional Chinese medicine composition for treating chronic viral hepatitis and preparation method thereof |
| 01/09/2008 | CN101099851A Compound abrus cantoniensis fish jelly paste preparation for preventing and treating viral hepatitis positive HBsAg, anti-HBc and anti-HBe to convert negative |
| 01/09/2008 | CN101099849A Medicine for treating cold and its preparing process |
| 01/09/2008 | CN101099846A Detumescence pain-relieving Babu plaster and preparing method |
| 01/09/2008 | CN101099840A Medicine composition for treating pulmonary tuberculosis |
| 01/09/2008 | CN101099824A Traditional Chinese medicine for treating acute appendicitis and preparing method thereof |
| 01/09/2008 | CN101099823A Traditional Chinese medicine for treating chronic appendicitis and preparing method thereof |
| 01/09/2008 | CN101099819A Traditional Chinese medicine for treating fungal vaginitis |
| 01/09/2008 | CN101099804A Traditional Chinese medicine composition for treating sars caused by epidemic poison retention lung and preparation method thereof |
| 01/09/2008 | CN101099787A Traditional Chinese medicinal composition with remarkable wide-spectrum antiviral action |
| 01/09/2008 | CN101099785A Traditional Chinese medicine capsule for treating diarrhea and dysentery |
| 01/09/2008 | CN101099765A Chaihuang preparation and its quality control method |
| 01/09/2008 | CN101099745A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/09/2008 | CN101099741A Alprostadil and vitamin F millimicroball composite medicine and its preparation method |
| 01/09/2008 | CN101099739A Enrofloxacin gelatine microball and its preparation method |
| 01/09/2008 | CN101099738A Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation |
| 01/09/2008 | CN101099722A Water agent for injecting containing recombinant human serum albumin-interferon alpha fusion protein |
| 01/09/2008 | CN101099566A Lactucin and its preparation method and application |
| 01/09/2008 | CN100360662C Preparation process and application of genetic engineering subunit vaccine of infectious bursal disease |
| 01/09/2008 | CN100360557C S protein of SARS virus, its vaccine and method for screening medicament using it |
| 01/09/2008 | CN100360556C Hepatitis B core antigen fusion proteins |
| 01/09/2008 | CN100360553C Compounds and use thereof to modify transport across cell membranes |
| 01/09/2008 | CN100360539C Preparation of plurichari |
| 01/09/2008 | CN100360536C Novel compounds and uses thereof |
| 01/09/2008 | CN100360534C Separation of regioisomers of metal phthalocyanines |
| 01/09/2008 | CN100360530C Crystalline 1-methylcarbapenem compounds |
| 01/09/2008 | CN100360525C Novel oxazolidone derivative, its preparing method and use |
| 01/09/2008 | CN100360523C 1,2,4 furodazole-phenoxyalkyl substituted derivative of iso-oxazole, preparation method and anti virus application |